Ryan Specialty (RYAN) EBITDA (2020 - 2025)
Ryan Specialty (RYAN) EBITDA from Mar 31, 2020 to Dec 31, 2025. The TTM Ryan Specialty (RYAN) EBITDA is $805M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Ryan Specialty (RYAN) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +34.54% |
| 3 Years TTM | +36.17% |
| 5 Years TTM | +33.24% |
| All Time TTM | +33.58% |
Annual EBITDA change of Ryan Specialty (RYAN)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | $803M | +34.15% |
| 2024 | $599M | +26.49% |
| 2023 | $473M | +20.33% |
| 2022 | $393M | +55.09% |
| 2021 | $254M | +30.58% |
| 2020 | $194M | +23.99% |
| 2019 | $157M | N/A |
Comparison Ryan Specialty (RYAN) five years EBITDA CAGR with competitors
Ryan Specialty (RYAN) five years EBITDA CAGR is 33.24%.
| Ticker | Name | five years EBITDA CAGR | Upside |
|---|---|---|---|
| AXS | Axis Capital Holdings Ltd | 39.19% | +17.89% |
| ESNT | Essent Group Ltd | 28.32% | -14.81% |
| NMIH | NMI Holdings Inc - Class A | 16.09% | -51.59% |
| MTG | MGIC Investment Corp | 8.27% | -75.13% |
| RDN | Radian Group Inc | 7.89% | -76.27% |